In addition, the quantitative loss of TRAF2-associated cIAP1 following bivalent IAP antagonist treatment correlated with inhibition of TNF-stimulated p65/NF-κB nuclear translocation and gene transcription in the cancer cell lines tested. Here, BIRC2 is linked to cancer.